These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10832500)

  • 1. Stability of meropenem in a portable infusion device in a cold pouch.
    Grant EM; Zhong MK; Ambrose PG; Nicolau DP; Nightingale CH; Quintiliani R
    Am J Health Syst Pharm; 2000 May; 57(10):992-5. PubMed ID: 10832500
    [No Abstract]   [Full Text] [Related]  

  • 2. Stability of meropenem and doripenem solutions for administration by continuous infusion.
    Berthoin K; Le Duff CS; Marchand-Brynaert J; Carryn S; Tulkens PM
    J Antimicrob Chemother; 2010 May; 65(5):1073-5. PubMed ID: 20176578
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability of meropenem in polyvinyl chloride bags and an elastomeric infusion device.
    Smith DL; Bauer SM; Nicolau DP
    Am J Health Syst Pharm; 2004 Aug; 61(16):1682-5. PubMed ID: 15540479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the stability of meropenem in intravenous mixtures.
    Takasu Y; Yoshida M; Tange M; Asahara K; Uchida T
    Chem Pharm Bull (Tokyo); 2015; 63(4):248-54. PubMed ID: 25832020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures.
    Franceschi L; Cojutti P; Baraldo M; Pea F
    Ther Drug Monit; 2014 Oct; 36(5):674-6. PubMed ID: 24637698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of meropenem in normal saline solution after storage at room temperature.
    Jaruratanasirikul S; Sriwiriyajan S
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):627-9. PubMed ID: 15115140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stability of a novel carbapenem antibiotic, meropenem (SM-7338), in a solid state formulation for injection.
    Takeuchi Y; Takebayashi Y; Sunagawa M; Isobe Y; Hamazume Y; Uemura A; Noguchi T
    Chem Pharm Bull (Tokyo); 1993 Nov; 41(11):1998-2002. PubMed ID: 8293523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of meropenem in intravenous solutions.
    Patel PR; Cook SE
    Am J Health Syst Pharm; 1997 Feb; 54(4):412-21. PubMed ID: 9043564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infections.
    Pai MP; Cojutti P; Pea F
    Clin Pharmacokinet; 2015 Sep; 54(9):933-41. PubMed ID: 25850987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Cyclodextrin complexation as an effective drug delivery system for meropenem.
    Paczkowska M; Mizera M; Szymanowska-Powałowska D; Lewandowska K; Błaszczak W; Gościańska J; Pietrzak R; Cielecka-Piontek J
    Eur J Pharm Biopharm; 2016 Feb; 99():24-34. PubMed ID: 26592156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incompatibility of ciprofloxacin and meropenem injections.
    Chen LY; Chen J; Waters V; Boodhan S
    Am J Health Syst Pharm; 2013 Nov; 70(22):1966, 1970. PubMed ID: 24173004
    [No Abstract]   [Full Text] [Related]  

  • 12. Compatibility of meropenem with commonly used injectable drugs.
    Patel PR
    Am J Health Syst Pharm; 1996 Dec; 53(23):2853-5. PubMed ID: 8957346
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the pharmacodynamics of meropenem in healthy volunteers following administration by intermittent infusion or bolus injection.
    Jaruratanasirikul S; Sriwiriyajan S
    J Antimicrob Chemother; 2003 Sep; 52(3):518-21. PubMed ID: 12917242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical efficacy of prolonged (4 hour) drip infusion of meropenem against severe pneumonia].
    Itabashi S
    Jpn J Antibiot; 2007 Jun; 60(3):161-70. PubMed ID: 17867490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of a 1 beta-methylcarbapenem antibiotic, meropenem (SM-7338) in aqueous solution.
    Takeuchi Y; Sunagawa M; Isobe Y; Hamazume Y; Noguchi T
    Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):689-92. PubMed ID: 7600618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous infusions of meropenem in ambulatory care: clinical efficacy, safety and stability.
    Manning L; Wright C; Ingram PR; Whitmore TJ; Heath CH; Manson I; Page-Sharp M; Salman S; Dyer J; Davis TM
    PLoS One; 2014; 9(7):e102023. PubMed ID: 25019523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional Versus Prolonged Infusion of Meropenem in Neonates With Gram-negative Late-onset Sepsis: A Randomized Controlled Trial.
    Shabaan AE; Nour I; Elsayed Eldegla H; Nasef N; Shouman B; Abdel-Hady H
    Pediatr Infect Dis J; 2017 Apr; 36(4):358-363. PubMed ID: 27918382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli.
    Lorente L; Lorenzo L; Martín MM; Jiménez A; Mora ML
    Ann Pharmacother; 2006 Feb; 40(2):219-23. PubMed ID: 16449546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended versus bolus infusion of meropenem and piperacillin: a pharmacokinetic analysis.
    De Waele J; Carlier M; Hoste E; Depuydt P; Decruyenaere J; Wallis SC; Lipman J; Roberts JA
    Minerva Anestesiol; 2014 Dec; 80(12):1302-9. PubMed ID: 24762706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation.
    Lee LS; Kinzig-Schippers M; Nafziger AN; Ma L; Sörgel F; Jones RN; Drusano GL; Bertino JS
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):251-8. PubMed ID: 20851549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.